1. ESTABLISHED PHARMACEUTICAL UNIT
HIMACHAL PRADESH

2. INDIAN PHARMA SECTOR
The Indian Pharmaceutical sector is highly fragmented, with more than 20,000 registered companies, with the top 250 companies controlling 70% of the market.
Those companies can currently meet about 70% of the countries demands for drugs, which account for 45% of the total number of Pharmaceutical manufacturing units of India.

3. BRIEF PROFILE OF DIRECTORS
MD of the company has experience of 36 years in this pharma line both in API’s n Formulations & Also have installed n designed many plants outside India.
Main R&D products of us are Vaccinations & Blood products, Oncology , Sugar free tab. N powder, ENO, Bournvita, Weight Gainer etc.
One of the director is quality control approved and handles all the R&D department.
One of the Director experienced in marketing field from 8 years.

4. FACT SHEET Established in the Year 2010 and excise benefit upto 2020.
The production unit is a large scale in size.
The company has established state of art manufacturing facility and having paramount building facilities.
Involved in marketing and distributing of pharma dosage form like tablet, Capsule, Liquid Orals, Ext. preparations etc & Food products.
Manufacturing unit managed by experienced technical staff for production and quality control along with expert technicians.
The plant is solely dedicated in the manufacturing of products for which it is to be licensed.
The major equipments are supplied by reputed manufactures in their field.
These are constructed as per international norms with the best materials available (GMP, WHO-GMP, USFDA Models).

5. SWOT ANALYSIS STRENGTHS WEAKNESS OPPORTUNITIES THREATS
1. Low cost of skilled manpower.
2. Strong marketing and distribution network.
3. Low cost of manufacturing and operations.
4. Access to highly trained scientists
5. Proven track record in design of high technology manufacturing devices
WEAKNESS
1. Stringent pricing regulations.
2. Lack of data protection.
3. Very competitive environment.
4. Low investment in innovative R&D
THREATS
1. Low cost countries affecting demand.
2. Wage inflation.
3. Counterfeiting threat
4. Expanding of drugs
5. Government regulations
OPPORTUNITIES
1. Increase in per capita income.
2. Significant investment from MNCs.
3. Global outsourcing.
4. Global demand for generics rising

6. QUALITY POLICY
It is an GMP certified company & can meet WHO-GMP standards & also USFDA.
Quality is a way of managing organization.
Provide quality product through focused research and innovative technology.
Improve quality consistently through highly qualified technocrats.
Maintain product quality & quality management system as per national and international standard.

7. PRODUCT PORTFOLIO

8. PRODUCTS Present facility Upcomings Tablets Injectables (dry n liquid)
Liquid orals
Dry Syrup
External Preparations
Eye-Ear drops
Capsules
Beta lactum
Food Products (Sugar free)
Oncology
Hormones
Vaccines n Blood Products
Ayurvedic cosmetics

9. INFRASTRUCTURE

10. AREA Total Build up area: 1,50,000 sq. ft. & Land : 15K sqMT.
Total area is divided into 10 blocks i.e.
Main Allopathic plant
Office n Administration
R&D CUM QC/QA
Warehouses
Security block
Utility area
Officers Flats
Tech. staff Quarters
Cancer block
Canteen

11. VENTILATION
Proper ventilation arrangements are provided as per the WHO-GMP norms.
In critical operational area air conditioning plant is provided.
Each core process room is supplied with controlled air passed through pre filters having efficiency of 99%.
The environmental parameters such as Particle monitoring, Temperature, Humidity, Air changes, Air pressure differentials, and Microbiological Monitoring are checked at periodic intervals.
Minimum 20 air changes are provided in all production area.
Day store Raw material store has been equipped with HVAC System.

12. OTHERS
No toxic or hazardous and sensitizing materials are handled in this facility.
The facility is highly specialized and designed for the exclusive use for manufacturing of Pharmaceutical Formulations & Food products .
There is bore well as a source of raw water for proper functioning of factory premises
The raw water is stored in a water storage tanks having capacity of 50,000 liter.
The treated DM water is pumped up in stainless steel (S.S. 304) storage tanks of 5000 liter capacity.
The regular cleaning of tanks & their record of cleaning is maintained.

13. PLANT & MACHINERY

14. QUALITY CONTROL HPLC Spectrophotometer(UV-Vis) Refractometer
Autoclave 30cm×30cm
Dissolution test apparatus
Digital Ph meter
Polari meter
Melting point apparatus
Incubator
Viscometer tube
Muffle furnace
Nesler cylinder
Humidity control oven 6 cubic feet

15. PRODUCTION Tablets RMG Octagonal blender FBD Sifters Paste kettle
Compressions
Coating pan
Blister pack
strip pack
MULTI MILL

16. CAPSULE SECTION Double Cone Blender Capsule Filling Sifter
Strip pack Machine
De-humidifier
Capsule loader

17. SYRUP SECTION & EXT. PREP.
SYRUP MFG. PLANT
SYRUP FILLING
PLANETARY MIXER
COLLOID MILL
EXT. PREP. MFG .PLANT
STORAGE TANKS

18. THANK YOU